Revolution Medicines Inc
(RVMD)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Sales | 9,460 | 1,101 | 8,698 | 10,131 | 8,751 |
| Gross Profit | 9,460 | 1,101 | 8,698 | 10,131 | 8,751 |
| Operating Expenses | 62,373 | 54,264 | 53,233 | 47,528 | 42,831 |
| Operating Income | -52,913 | -53,163 | -44,535 | -37,397 | -34,080 |
| Interest Expense | 0 | 0 | 0 | 12 | 14 |
| Other Income | 237 | 223 | 236 | 233 | 252 |
| Pre-tax Income | -52,676 | -52,940 | -44,299 | -37,176 | -33,842 |
| Income Tax | N/A | N/A | N/A | N/A | 362 |
| Net Income Continuous | -52,676 | -52,940 | -44,299 | -37,176 | -34,204 |
| Net Income | $-52,676 | $-52,940 | $-44,299 | $-37,176 | $-34,204 |
| EPS Basic Total Ops | -0.72 | -0.72 | -0.60 | -0.53 | -0.39 |
| EPS Basic Continuous Ops | -0.72 | -0.72 | -0.60 | -0.53 | -0.42 |
| EPS Diluted Total Ops | -0.72 | -0.72 | -0.60 | -0.53 | -0.39 |
| EPS Diluted Continuous Ops | -0.72 | -0.72 | -0.60 | -0.53 | -0.42 |
| EBITDA(a) | $-49,959 | $-50,519 | $-42,001 | $-35,185 | $-31,794 |